Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
5.07
-0.15 (-2.87%)
May 18, 2026, 9:42 AM EDT - Market open
Replimune Group Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Replimune Group stock has a consensus rating of "Sell" and an average price target of $3.50. The average 1-year stock price forecast is 30.97% lower than the current stock price, while the lowest is $1.00 (-80.28%) and the highest is $10 (+97.24%).
Price Target: $3.50 (-30.97%)
Analyst Consensus: Sell
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
The average analyst rating for Replimune Group stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 0 | 0 |
| Buy | 4 | 4 | 4 | 4 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 13, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $11 → $2 | Buy → Hold | Downgrades | $11 → $2 | -60.55% | Apr 13, 2026 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Apr 13, 2026 |
| Wedbush | Wedbush | Buy → Hold Downgrades $19 → $2 | Buy → Hold | Downgrades | $19 → $2 | -60.55% | Apr 13, 2026 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | -60.55% | Apr 13, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
9.01M
EPS This Year
-3.43
from -3.07
EPS Next Year
-1.95
from -3.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | 38.6M | ||||||
| Avg | n/a | 9.0M | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -3.30 | -0.83 | ||||||
| Avg | -3.43 | -1.95 | ||||||
| Low | -3.47 | -2.66 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.